CK2 is highly expressed in various cancers and exerts oncogenic functions by activating several major signaling pathways, such as MAPK/ERK, PI3K/AKT, IKK/NFκB and Wnt/β-catenin pathways [39, 54, 55]. The gene discussed is NFKB1; the disease is cancer.